Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,353 | 121 | 93.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $107.81 | 1 | 4.3% |
| Education | $44.03 | 12 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $573.42 | 59 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $435.99 | 14 | $0 (2023) |
| ABBVIE INC. | $384.88 | 14 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $221.08 | 2 | $0 (2017) |
| Indivior Inc. | $219.21 | 9 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $165.14 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $133.19 | 8 | $0 (2024) |
| Alkermes, Inc. | $72.79 | 5 | $0 (2022) |
| Lundbeck LLC | $71.88 | 4 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $58.29 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $206.83 | 6 | ABBVIE INC. ($113.46) |
| 2023 | $179.87 | 6 | ABBVIE INC. ($151.11) |
| 2022 | $196.91 | 14 | ABBVIE INC. ($74.87) |
| 2021 | $290.93 | 19 | Sunovion Pharmaceuticals Inc. ($91.59) |
| 2020 | $246.08 | 10 | Otsuka America Pharmaceutical, Inc. ($109.41) |
| 2019 | $321.66 | 22 | Teva Pharmaceuticals USA, Inc. ($137.50) |
| 2018 | $294.69 | 31 | Sunovion Pharmaceuticals Inc. ($123.20) |
| 2017 | $767.92 | 26 | ACADIA Pharmaceuticals Inc ($221.08) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Opioid Use Disorder | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Neuroscience | ||||||
| 06/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Neuroscience | ||||||
| 05/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Neuroscience | ||||||
| 03/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Neuroscience | ||||||
| 09/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.42 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Central Nervous System | ||||||
| 02/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: CNS | ||||||
| 07/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: CNS | ||||||
| 06/13/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: CNS | ||||||
| 05/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: CNS | ||||||
| 04/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: CNS | ||||||
| 03/07/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 03/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 101 | 869 | $134,600 | $68,327 |
| 2022 | 2 | 71 | 714 | $104,200 | $56,309 |
| 2021 | 3 | 87 | 842 | $127,400 | $64,289 |
| 2020 | 3 | 105 | 1,085 | $163,300 | $76,004 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 360 | $72,000 | $37,044 | 51.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 38 | 400 | $40,000 | $22,185 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 93 | $18,600 | $6,920 | 37.2% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 16 | 16 | $4,000 | $2,177 | 54.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 328 | $65,600 | $34,283 | 52.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 38 | 386 | $38,600 | $22,026 | 57.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 300 | $60,000 | $31,525 | 52.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 43 | 410 | $41,000 | $23,120 | 56.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 132 | $26,400 | $9,644 | 36.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 364 | $72,800 | $32,896 | 45.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 49 | 537 | $53,700 | $31,755 | 59.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 184 | $36,800 | $11,352 | 30.8% |
About Dr. Daud Panah, MD
Dr. Daud Panah, MD is a Psychiatry healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831239649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daud Panah, MD has received a total of $2,505 in payments from pharmaceutical and medical device companies, with $206.83 received in 2024. These payments were reported across 134 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,353).
As a Medicare-enrolled provider, Panah has provided services to 364 Medicare beneficiaries, totaling 3,510 services with total Medicare billing of $264,929. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Marlton, NJ
- Active Since 02/08/2007
- Last Updated 09/11/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1831239649
Products in Payments
- LATUDA (Drug) $573.42
- VRAYLAR (Drug) $441.78
- REXULTI (Drug) $274.34
- ABILIFY MAINTENA (Drug) $233.53
- NUPLAZID (Drug) $221.08
- AUSTEDO (Drug) $150.39
- SUBOXONE SUBLINGUAL FILM (Drug) $147.72
- INVEGA (Drug) $78.47
- SUBLOCADE (Drug) $71.49
- ARISTADA (Drug) $54.91
- TRINTELLIX (Drug) $40.97
- INVEGA SUSTENNA (Drug) $40.73
- HETLIOZ (Drug) $29.64
- Aristada 441 mg (Drug) $17.88
- Trintellix (Drug) $16.30
- CAPLYTA (Drug) $16.05
- BRIXADI (Drug) $14.90
- Hetlioz (Drug) $14.89
- SD809-TD (Drug) $14.75
- SPRAVATO (Drug) $13.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Marlton
Dr. Lloyd Alcera, M.d, M.D
Psychiatry — Payments: $212,743
Margaret Harbison, Md, MD
Psychiatry — Payments: $2,665
Ann Steel, Md, MD
Psychiatry — Payments: $2,408
Dr. George Ellis, M.d, M.D
Psychiatry — Payments: $2,262
Dr. Maju Mathews, Md, MD
Psychiatry — Payments: $2,245
Jake Rosenberg
Psychiatry — Payments: $1,963